Form 4: Cadrenal Therapeutics CEO Quang Pham Donates 50,000 Shares to Non-Profit

CEO Quang Pham of Cadrenal Therapeutics donates 50,000 shares of common stock to a non-profit organization on April 10, 2024.

Summary

• On April 10, 2024, Quang Pham, CEO and Chairman of Cadrenal Therapeutics, Inc., donated 50,000 shares of common stock to a non-profit organization.
• The donation was made as a gift with no value received, pursuant to a written agreement.
• Following the transaction, Pham directly owns 3,275,000 shares of Cadrenal Therapeutics common stock.
• Pham also indirectly owns 3,000,000 shares through The PVBQ Living Trust, where he serves as trustee and his child is the sole beneficiary.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing related to a stock donation. It doesn't inherently convey positive or negative sentiment about the company's performance, but the donation itself could be seen as a neutral to slightly positive gesture.

Positives

• The donation to a non-profit organization could be viewed positively from a corporate social responsibility perspective.

Industry Context

Executive stock donations are not uncommon and can be motivated by personal philanthropy or tax considerations. The impact on the company is generally minimal unless the donation is exceptionally large or signals a change in the executive's confidence in the company.

Stakeholder Impact

• The donation has a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.

Key Dates